DIABETIC NEPHROPATHY

This adverse event was reported 1667 times

These drugs are most commonly taken by patients reporting DIABETIC NEPHROPATHY:

# Drug Count
0 LANSOPRAZOLE 500
1 OMEPRAZOLE MAGNESIUM 384
2 OMEPRAZOLE 311
3 ESOMEPRAZOLE MAGNESIUM 238
4 PANTOPRAZOLE 234
5 FUROSEMIDE 175
6 QUETIAPINE 161
7 ESOMEPRAZOLE 157
8 LANSOPRAZOLE DELAYED RELEASE 154
9 ASPIRIN 151
See all common drugs associated with DIABETIC NEPHROPATHY

DIABETIC NEPHROPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 10 0.0030
1 Insulin [EPC] 74 0.0018
2 Vitamin D2 Analog [EPC] 2 0.0016
3 Glinide [EPC] 15 0.0015
4 Proton Pump Inhibitor [EPC] 538 0.0014
5 Interleukin-2 Receptor Blocking Antibody [EPC] 9 0.0013
6 Blood Viscosity Reducer [EPC] 3 0.0012
7 Sulfonylurea [EPC] 127 0.0011
8 alpha-Hydroxy Acid [EPC] 1 0.0011
9 Phosphodiesterase 3 Inhibitor [EPC] 4 0.0009
See all drug classes enriched for association with DIABETIC NEPHROPATHY